Clinical Trial: A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of SHR-2173 in Patients With Systemic Lupus Erythematosus

U.S., May 3 -- ClinicalTrials.gov registry received information related to the study (NCT06955598) titled 'A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of SHR-2173 in Patients With Systemic Lupus Erythematosus' on April 08.

Brief Summary: To investigate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of multiple subcutaneous injections of SHR-2173 in patients with systemic lupus erythematosus (SLE).

Study Start Date: Nov. 24, 2024

Study Type: INTERVENTIONAL

Condition: Systemic Lupus Erythematosus

Intervention: DRUG: SHR-2173

SHR-2173

Recruitment Status: RECRUITING

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd...